Boston Scientific Hopes New Data Will Expand Boundaries Of DES Population
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific expects the new data from two trials released at the Transcatheter Cardiovascular Therapeutics Scientific Symposium in Washington, D.C., last week will encourage physicians to reconsider drug-eluting stents for a broader range of patients